Literature DB >> 18262042

Pathogenic flaviviruses.

E A Gould1, T Solomon.   

Abstract

Haemorrhagic disease, encephalitis, biphasic fever, flaccid paralysis, and jaundice are typical manifestations of diseases in human beings after infections by mosquito-borne or tick-borne flaviviruses such as yellow fever, dengue, West Nile, St Louis encephalitis, Japanese encephalitis, tick-borne encephalitis, Kyasanur Forest disease, and Omsk haemorrhagic fever. Although the characteristics of these viruses are well defined, they are still unpredictable with increases in disease severity, unusual clinical manifestations, unexpected methods of transmission, long-term persistence, and the discovery of new species. This Seminar will compare the epidemiological and clinical features of the medically important flaviviruses, consider the effect of human activity on their evolution and dispersal, and draw attention to new findings and some of the unanswered questions, unresolved issues, and controversies that remain.

Entities:  

Mesh:

Year:  2008        PMID: 18262042     DOI: 10.1016/S0140-6736(08)60238-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  255 in total

1.  Human macrophage SCN5A activates an innate immune signaling pathway for antiviral host defense.

Authors:  Alexis Jones; Danielle Kainz; Faatima Khan; Cara Lee; Michael D Carrithers
Journal:  J Biol Chem       Date:  2014-11-03       Impact factor: 5.157

2.  Exploiting mosquito sugar feeding to detect mosquito-borne pathogens.

Authors:  Sonja Hall-Mendelin; Scott A Ritchie; Cheryl A Johansen; Paul Zborowski; Giles Cortis; Scott Dandridge; Roy A Hall; Andrew F van den Hurk
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

3.  Complete genomic sequence of duck flavivirus from china.

Authors:  Ming Liu; Chunguo Liu; Gang Li; Xiaojun Li; Xiuchen Yin; Yuhuan Chen; Yun Zhang
Journal:  J Virol       Date:  2012-03       Impact factor: 5.103

4.  NIAID workshop on Flavivirus immunity.

Authors:  Alison D Augustine; M Cristina Cassetti; Francis A Ennis; Eva Harris; William H Hildebrand; Patricia M Repik
Journal:  Viral Immunol       Date:  2010-06       Impact factor: 2.257

5.  Tick-borne Encephalitis Vaccines.

Authors:  Axel T Lehrer; Michael R Holbrook
Journal:  J Bioterror Biodef       Date:  2011

6.  Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.

Authors:  Eloise Mastrangelo; Margherita Pezzullo; Tine De Burghgraeve; Suzanne Kaptein; Boris Pastorino; Kai Dallmeier; Xavier de Lamballerie; Johan Neyts; Alicia M Hanson; David N Frick; Martino Bolognesi; Mario Milani
Journal:  J Antimicrob Chemother       Date:  2012-04-25       Impact factor: 5.790

7.  Molecular characterization of a duck Tembusu virus from China.

Authors:  XiaoFei Bai; Rang Lv; ChunGuo Liu; Na Qiu; Yilong He; XiuChen Yin; XiaoJun Li; Ming Liu; Yun Zhang
Journal:  Virus Genes       Date:  2013-08-15       Impact factor: 2.332

8.  Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.

Authors:  Alexander J McAuley; Maricela Torres; Jessica A Plante; Claire Y-H Huang; Dennis A Bente; David W C Beasley
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 9.  Closing the door on flaviviruses: entry as a target for antiviral drug design.

Authors:  Rushika Perera; Mansoora Khaliq; Richard J Kuhn
Journal:  Antiviral Res       Date:  2008-06-11       Impact factor: 5.970

10.  JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.

Authors:  Maximilian Larena; Natalie A Prow; Roy A Hall; Nikolai Petrovsky; Mario Lobigs
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.